Literature DB >> 9822440

Chamber-specific alterations of norepinephrine uptake sites in cardiac hypertrophy.

M Böhm1, M Castellano, M Flesch, C Maack, M Moll, M Paul, F Schiffer, O Zolk.   

Abstract

The present study investigated local differences of sympathetic activation and sympathetic neuroeffector defects in nonhypertrophied right and hypertrophied left ventricles in a rat model with renin-induced pressure overload [TG(mREN2)27]. As judged from the depletion of myocardial norepinephrine stores, sympathetic activation was more pronounced in the left than in the right ventricles. In addition, norepinephrine uptake1 carrier sites were reduced in left but unchanged in right ventricles. Gene expression of the carrier was unchanged in stellate ganglia. An increase of Gialpha expression and a heterologous adenylyl cyclase desensitization occurred only in the left but not in the right ventricles, whereas a reduction of beta-adrenergic receptors was observed in both chambers. We concluded that general sympathetic activation can lead to beta-adrenoceptor downregulation but that pressure overload further increases sympathetic activation involving norepinephrine uptake mechanisms in the left ventricles, resulting in heterologous beta-adrenergic desensitization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822440     DOI: 10.1161/01.hyp.32.5.831

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats.

Authors:  K Leineweber; T Seyfarth; O E Brodde
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Expressions of cardiac sympathetic norepinephrine transporter and beta1-adrenergic receptor decreased in aged rats.

Authors:  He Li; Xiao-qing Ma; Fan Ye; Jing Zhang; Xin Zhou; Zhi-hong Wang; Yu-ming Li; Guo-yuan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

3.  Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.

Authors:  Ewa Soltysinska; Stefanie Thiele; Søren Peter Olesen; Oleg E Osadchii
Journal:  Pflugers Arch       Date:  2011-08-03       Impact factor: 3.657

4.  Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content.

Authors:  Erica A Wehrwein; Lindsay M Parker; Anna A Wright; John M Spitsbergen; Martin Novotny; Dagmar Babankova; Greg M Swain; Beth A Habecker; David L Kreulen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-18       Impact factor: 3.619

5.  Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density.

Authors:  David M Raffel; Wei Chen; Phillip S Sherman; David L Gildersleeve; Yong-Woon Jung
Journal:  J Nucl Med       Date:  2006-09       Impact factor: 10.057

6.  Determination of endogenous norepinephrine levels in different chambers of the rat heart by capillary electrophoresis coupled with amperometric detection.

Authors:  Martin Novotny; Veronika Quaiserová-Mocko; Erica A Wehrwein; David L Kreulen; Greg M Swain
Journal:  J Neurosci Methods       Date:  2007-02-16       Impact factor: 2.390

7.  Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies.

Authors:  David M Raffel; Wei Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-22       Impact factor: 3.000

8.  Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations.

Authors:  Inna Belfer; Gabriel Phillips; Julie Taubman; Heather Hipp; Robert H Lipsky; Mary-Anne Enoch; Mitchell B Max; David Goldman
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

9.  Further evidence of association between amphetamine response and SLC6A2 gene variants.

Authors:  Andrea M Dlugos; Ajna Hamidovic; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2009-10       Impact factor: 4.530

10.  Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome.

Authors:  Jana K Shirey-Rice; Rebecca Klar; Hugh M Fentress; Sarah N Redmon; Tiffany R Sabb; Jessica J Krueger; Nathan M Wallace; Martin Appalsamy; Charlene Finney; Suzanna Lonce; André Diedrich; Maureen K Hahn
Journal:  Dis Model Mech       Date:  2013-04-04       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.